Suzhou Novoprotein (China) Buy Hold or Sell Recommendation
| 688137 Stock | 36.77 0.52 1.43% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Suzhou Novoprotein Scientific is 'Strong Sell'. Macroaxis provides Suzhou Novoprotein buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 688137 positions.
Check out Suzhou Novoprotein Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Suzhou and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Suzhou Novoprotein Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Suzhou |
Execute Suzhou Novoprotein Buy or Sell Advice
The Suzhou recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Suzhou Novoprotein Scientific. Macroaxis does not own or have any residual interests in Suzhou Novoprotein Scientific or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Suzhou Novoprotein's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Suzhou Novoprotein Trading Alerts and Improvement Suggestions
| Suzhou Novoprotein had very high historical volatility over the last 90 days | |
| Suzhou Novoprotein has high likelihood to experience some financial distress in the next 2 years | |
| About 73.0% of the company shares are owned by insiders or employees |
Suzhou Novoprotein current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Suzhou analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Suzhou analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Suzhou Novoprotein Returns Distribution Density
The distribution of Suzhou Novoprotein's historical returns is an attempt to chart the uncertainty of Suzhou Novoprotein's future price movements. The chart of the probability distribution of Suzhou Novoprotein daily returns describes the distribution of returns around its average expected value. We use Suzhou Novoprotein Scientific price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Suzhou Novoprotein returns is essential to provide solid investment advice for Suzhou Novoprotein.
| Mean Return | 0.39 | Value At Risk | -3.13 | Potential Upside | 5.14 | Standard Deviation | 2.95 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Suzhou Novoprotein historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Suzhou Novoprotein Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Suzhou Novoprotein or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Suzhou Novoprotein's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Suzhou stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.37 | |
β | Beta against Dow Jones | 0.06 | |
σ | Overall volatility | 3.13 | |
Ir | Information ratio | 0.09 |
Suzhou Novoprotein Volatility Alert
Suzhou Novoprotein Scientific shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Suzhou Novoprotein's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Suzhou Novoprotein's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Suzhou Novoprotein Fundamentals Vs Peers
Comparing Suzhou Novoprotein's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Suzhou Novoprotein's direct or indirect competition across all of the common fundamentals between Suzhou Novoprotein and the related equities. This way, we can detect undervalued stocks with similar characteristics as Suzhou Novoprotein or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Suzhou Novoprotein's fundamental indicators could also be used in its relative valuation, which is a method of valuing Suzhou Novoprotein by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Suzhou Novoprotein to competition |
| Fundamentals | Suzhou Novoprotein | Peer Average |
| Return On Equity | -0.0099 | -0.31 |
| Return On Asset | -0.0228 | -0.14 |
| Profit Margin | (0.16) % | (1.27) % |
| Operating Margin | 0.58 % | (5.51) % |
| Current Valuation | 1.95 B | 16.62 B |
| Shares Outstanding | 70.18 M | 571.82 M |
| Shares Owned By Insiders | 72.80 % | 10.09 % |
| Shares Owned By Institutions | 5.55 % | 39.21 % |
| Price To Book | 1.19 X | 9.51 X |
| Price To Sales | 19.28 X | 11.42 X |
| Revenue | 153.19 M | 9.43 B |
| Gross Profit | 228.37 M | 27.38 B |
| EBITDA | (71.71 M) | 3.9 B |
| Net Income | 12.84 M | 570.98 M |
| Total Debt | 11.08 M | 5.32 B |
| Book Value Per Share | 29.05 X | 1.93 K |
| Cash Flow From Operations | 69.16 M | 971.22 M |
| Earnings Per Share | (0.31) X | 3.12 X |
| Number Of Employees | 579 | 18.84 K |
| Beta | 2.14 | -0.15 |
| Market Capitalization | 2.54 B | 19.03 B |
| Total Asset | 2.3 B | 29.47 B |
| Retained Earnings | 149.52 M | 9.33 B |
| Working Capital | 2.02 B | 1.48 B |
| Annual Yield | 0.01 % | |
| Net Asset | 2.3 B | |
| Last Dividend Paid | 0.5 |
Suzhou Novoprotein Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Suzhou . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Suzhou Novoprotein Buy or Sell Advice
When is the right time to buy or sell Suzhou Novoprotein Scientific? Buying financial instruments such as Suzhou Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Suzhou Novoprotein in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sports Thematic Idea Now
Sports
Companies in sporting activities arena as well as manufacturers of sporting goods and sport retailers. The Sports theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sports Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Suzhou Stock
Suzhou Novoprotein financial ratios help investors to determine whether Suzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Suzhou with respect to the benefits of owning Suzhou Novoprotein security.